Saba Capital Management’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Saba Capital Management’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-999,888	Closed	-$47.8K	–	792
2023 Q1	$47.8K	Hold	999,888	–	–	﹤0.01%	549
2022 Q4	$25.9K	Hold	999,888	–	–	﹤0.01%	710
2022 Q3	$104K	Hold	999,888	–	–	﹤0.01%	767
2022 Q2	$142K	Hold	999,888	–	–	﹤0.01%	793
2022 Q1	$278K	Buy	999,888 +215,100	+27%	+$78.4K	﹤0.01%	698
2021 Q4	$385K	Buy	+784,788	New	+$394K	0.01%	644

Saba Capital Management's IQMDW Position: Q2 2023 in Review

Saba Capital Management sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 999,888 shares — an estimated $47.8K sold.

Saba Capital Management first reported a position in IQMDW in Q4 2021 and held it in 6 quarters. The position peaked at $385K in Q4 2021. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

Saba Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Saba Capital Management sold 999,888 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $47.8K.
Saba Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q4 2021 and held it in 6 quarters.
Saba Capital Management's Intelligent Medicine Acquisition Corp. Warrant position peaked at $385K in Q4 2021.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Saba Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.